Compare EVO & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | PNTG |
|---|---|---|
| Founded | 1993 | 2019 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 994.5M | 1.0B |
| IPO Year | N/A | 2019 |
| Metric | EVO | PNTG |
|---|---|---|
| Price | $2.72 | $32.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $7.00 | ★ $37.00 |
| AVG Volume (30 Days) | 28.7K | ★ 211.0K |
| Earning Date | 04-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $947,705,000.00 |
| Revenue This Year | $1.37 | $24.72 |
| Revenue Next Year | $10.05 | $7.61 |
| P/E Ratio | ★ N/A | $136.58 |
| Revenue Growth | N/A | ★ 36.31 |
| 52 Week Low | $2.31 | $21.74 |
| 52 Week High | $4.42 | $37.54 |
| Indicator | EVO | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 50.09 |
| Support Level | $2.63 | $28.05 |
| Resistance Level | $3.82 | $35.13 |
| Average True Range (ATR) | 0.07 | 1.52 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 27.55 | 56.93 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.